Home
About Idogen
Idogen in brief
Management team
Board of directors
Scientific advisory board
Business concept
Horizon 2020
Career
R&D
Idogen´s technology
Research overview
Project portfolio
Research collaborations
Investors
Stock information
Owners
Certified advisor
Analysts
Financial reports
Financial calendar
Presentations
Upcoming events
Investors contact
News & Media
News
Interviews
Contact us
Search
Menu
Upcoming events
More events will be announced shortly
Idogen develops tolerogenic cell therapy – individualised treatment for each patient
Scroll to top
